Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50,239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The level of macrophage migration inhibitory factor is negatively correlated with the efficacy of PD-1 blockade immunotherapy combined with chemotherapy as a neoadjuvant therapy for esophageal squamous cell carcinoma.
Wu L, Gao Y, Xie S, Ye W, Uemura Y, Zhang R, Yu Y, Li J, Chen M, Wu Q, Cui P, Liu H, Mu S, Li Y, Wang L, Liu C, Li J, Zhang L, Jiao S, Zhang G, Liu T. Wu L, et al. Among authors: chen m. Transl Oncol. 2023 Nov;37:101775. doi: 10.1016/j.tranon.2023.101775. Epub 2023 Sep 6. Transl Oncol. 2023. PMID: 37678132 Free PMC article.
Impact of docetaxel plus ramucirumab therapy on interstitial lung disease in recurrent advanced non-small cell lung cancer patients.
Ebi N, Inoue H, Fujimoto Y, Chen M, Sanai R, Kushima N, Osaki Y, Ikeda T, Nakao A, Shundo Y, Yanagihara T, Hamada N, Fujita M. Ebi N, et al. Among authors: chen m. Transl Lung Cancer Res. 2024 Oct 31;13(10):2573-2584. doi: 10.21037/tlcr-24-460. Epub 2024 Oct 28. Transl Lung Cancer Res. 2024. PMID: 39507040 Free PMC article.
TQB2450 with or without anlotinib as maintenance treatment in subjects with locally advanced/unresectable non-small cell lung cancer that have not progressed after prior concurrent/sequential chemoradiotherapy (R-ALPS): study protocol for a randomized, double-blind, placebo-controlled, multicenter phase III trial.
Dong B, Chen L, Pang Q, Jiang O, Ge H, Cheng Y, Zhou R, Meng X, Li J, Zhu X, Wang X, Cao Q, Ji Y, Chen M. Dong B, et al. Among authors: chen m. Transl Lung Cancer Res. 2024 Oct 31;13(10):2828-2837. doi: 10.21037/tlcr-24-362. Epub 2024 Oct 28. Transl Lung Cancer Res. 2024. PMID: 39507039 Free PMC article.
50,239 results
You have reached the last available page of results. Please see the User Guide for more information.